SSRIs and Antidepressants During Pregnancy: What You Need to Know About Risks and Benefits

When you're pregnant and struggling with depression or anxiety, the question isn't just whether to take an SSRI-it's whether not taking one might be riskier. Around 1 in 7 pregnant women experience depression or anxiety severe enough to need treatment. But the fear of harming the baby often leads to silence, or worse, stopping medication cold turkey. That’s not just risky-it’s dangerous.

What SSRIs Actually Do

SSRIs, or selective serotonin reuptake inhibitors, are the most common type of antidepressant used today. They work by helping your brain hold onto more serotonin, a chemical that affects mood, sleep, and appetite. Medications like sertraline (Zoloft), citalopram (Celexa), escitalopram (Lexapro), and fluoxetine (Prozac) have been used for decades. Fluoxetine was the first, approved in 1987. Since then, millions of pregnant women have taken them. And the data? It’s clearer now than ever.

These drugs cross the placenta, but not as much as you might think. Sertraline, for example, transfers at about 60-70% efficiency from mother to baby. That’s enough to help, but not so much that it floods the fetal system. The key is using the lowest dose that works. Most doctors start with 25-50 mg of sertraline daily and adjust slowly.

The Real Risk: Untreated Depression

The biggest danger isn’t the medication-it’s the illness itself. Untreated depression during pregnancy increases the risk of preterm birth by more than double. It raises the chance of low birth weight. It makes postpartum depression far more likely-nearly 15% of women with untreated antenatal depression develop it, compared to just 5% when treated.

And then there’s suicide. In the U.S., suicide accounts for 20% of all pregnancy-related deaths. That’s not a footnote. It’s the leading cause. Substance use also spikes: 25% of untreated depressed pregnant women turn to alcohol or drugs, compared to 8% of those on treatment. Bonding with your baby? That’s harder, too. Studies show mothers with untreated depression score 30% lower on attachment scales after birth.

When you stop your SSRI during pregnancy, the relapse rate is terrifying. One 2022 study found that 92% of women who stopped their medication had a full depressive relapse. Only 21% of those who kept taking it did. That’s not a small difference. That’s life or death.

What About Birth Defects?

You’ve probably heard that SSRIs cause heart defects. That’s mostly about paroxetine (Paxil). It’s the only SSRI with a clear, small increase in septal heart defects-rising from a baseline of 0.5% to about 0.7-1.0%. That’s still less than 1 in 100. For that reason, paroxetine is avoided entirely in the first trimester.

But the other SSRIs? Sertraline, citalopram, escitalopram, fluoxetine? Large studies of over 1.8 million births found no meaningful increase in major birth defects. The absolute risk difference between women taking SSRIs and those not taking them? Just 0.3%. That’s not a signal. That’s noise.

The FDA changed its labeling system in 2015 to stop using vague categories like “Category C.” Now, labels must say exactly what the data shows. Most SSRIs now carry a summary that reads: “No substantial evidence of increased major congenital malformations.”

Pregnant woman in consultation with doctor and therapist, with placenta showing safe serotonin flow.

What About PPHN and Preterm Birth?

Persistent Pulmonary Hypertension of the Newborn (PPHN) is a rare but serious lung condition. In the general population, it affects 1-2 in 1,000 babies. With SSRI use in the third trimester, that number goes up to 3-6 in 1,000. That sounds scary-but remember, it’s still less than 1% of exposed babies. And when you adjust for how severe the mother’s depression was, the link weakens. Severe depression itself increases PPHN risk.

Preterm birth (before 37 weeks) happens in about 12.5% of SSRI-exposed pregnancies versus 9.5% in depressed women not on meds. But here’s the catch: those not on meds often have worse depression. When researchers compared women with similar depression severity, the difference vanished. The real driver? Depression, not the drug.

Neurodevelopment: The Long-Term Question

This is where things get messy. Some studies suggest children exposed to SSRIs in utero might have slightly higher rates of autism or anxiety later in life. A 2022 JAMA Pediatrics paper reported a 1.3-fold increase in autism risk. But a 2021 Lancet study, which controlled for family history and genetics, found no link at all. The difference? One study compared babies of depressed moms on meds to babies of non-depressed moms. The other compared babies of depressed moms-with and without meds.

Columbia University researchers found that by age 15, 28% of children exposed to SSRIs in utero had depression, compared to 12% of children whose moms had depression but didn’t take meds. But here’s the flaw: those moms likely had more severe, chronic depression. And depression runs in families. The medication might not be the cause-the genetic risk is.

The NIH’s 2023 review put it bluntly: “Animal studies can’t replicate human complexity.” Mouse brains don’t have social stressors, parenting pressures, or access to therapy. Human outcomes are shaped by a thousand variables. SSRIs might be one of them-but not the biggest.

Mother breastfeeding baby with protective shield and timeline showing life paths of treated vs untreated depression.

What About Breastfeeding?

If you’re planning to breastfeed, sertraline is still the top pick. It transfers in very low amounts into breast milk-so low that infant blood levels are often undetectable. Fluoxetine lingers longer and can build up, so it’s less ideal. Most experts agree: the benefits of breastfeeding almost always outweigh the tiny amount of medication passed along.

Infants exposed to SSRIs through breast milk rarely show side effects. If they do, it’s usually mild fussiness or sleep changes-and those usually fade within weeks. The American Academy of Pediatrics considers SSRIs compatible with breastfeeding.

What Should You Do?

If you’re pregnant and on an SSRI, don’t stop. Not without talking to your doctor. Abruptly quitting leads to withdrawal symptoms in 73% of cases: dizziness, nausea, brain zaps, even rebound anxiety. That’s not safe for you-or your baby.

Here’s what experts recommend:

  1. Stick with sertraline if you’re on an SSRI already. It has the best safety profile.
  2. Avoid paroxetine entirely during pregnancy.
  3. Use the lowest effective dose. Don’t increase unless necessary.
  4. Monitor for gestational hypertension-SSRIs slightly raise the risk (8.5% vs. 6.2% in controls).
  5. Don’t switch medications unless you have to. Switching increases relapse risk.
  6. If you’re considering stopping, do it slowly-over 4 to 6 weeks-with weekly depression checks.

And talk about your fears. Not just with your OB-GYN, but with a therapist or psychiatrist who specializes in perinatal care. You’re not weak for needing help. You’re not selfish for choosing to stay well. You’re doing the hardest thing a parent can do: putting your health first so you can be there for your child.

What’s Next?

In September 2025, the NIH launched a $15 million study tracking 10,000 mother-child pairs to see how SSRI exposure affects kids into adolescence. Results won’t come until 2030. But we already know enough to make smart choices.

The American Psychiatric Association now recommends matching SSRIs to symptom types: sertraline for anxiety-heavy depression, fluoxetine for low energy, citalopram for trouble sleeping. Personalized treatment isn’t a luxury-it’s the standard.

Future research is focused on two things: drugs that don’t cross the placenta as easily, and genetic tests that tell you how your body breaks down SSRIs. About 40% of people have genetic variants that make them slow or fast metabolizers. That affects dosing and side effects. We’re getting closer to precision medicine in pregnancy.

For now, the message is simple: untreated depression is far more dangerous than SSRIs. The risks of the medication are small, measurable, and manageable. The risks of silence? They’re not.

Is it safe to take sertraline while pregnant?

Yes. Sertraline is considered the safest SSRI for pregnancy. It has the lowest risk of birth defects, minimal placental transfer, and is compatible with breastfeeding. Large studies of over a million births show no significant increase in major malformations. It’s the first-line choice for pregnant women needing antidepressant treatment.

Can SSRIs cause autism in babies?

Current evidence doesn’t support a clear link. Some early studies suggested a small increase, but those didn’t account for genetic and environmental factors shared between mothers and children. A major 2021 Lancet study, which compared siblings exposed and unexposed to SSRIs, found no increased autism risk. The consensus among maternal-fetal medicine experts is that any observed link is likely due to underlying depression, not the medication.

What happens if I stop my SSRI during pregnancy?

Stopping abruptly can trigger severe withdrawal symptoms like dizziness, nausea, brain zaps, and rebound anxiety. More importantly, you face a 92% chance of depressive relapse. Untreated depression increases risks of preterm birth, low birth weight, and postpartum depression. If you want to stop, do it slowly-over 4-6 weeks-with close monitoring by your doctor.

Are there any SSRIs I should avoid during pregnancy?

Yes. Paroxetine (Paxil) should be avoided because it’s linked to a small but increased risk of heart defects in the first trimester. Other SSRIs like sertraline, citalopram, escitalopram, and fluoxetine are considered safe. The key is to stay on the medication that’s working for you rather than switching unless there’s a clear reason.

Can I take SSRIs while breastfeeding?

Yes. Sertraline passes into breast milk in very low amounts-often too low to measure in the baby’s blood. Fluoxetine can build up over time and is less ideal. Most experts agree the benefits of breastfeeding outweigh the minimal medication exposure. Babies rarely show side effects, and if they do, symptoms usually fade within weeks.

How do I know if I need an SSRI during pregnancy?

If your depression or anxiety is interfering with your daily life-sleep, eating, working, bonding with loved ones-you likely need treatment. Mild symptoms might respond to therapy or lifestyle changes. But moderate to severe depression carries real risks to you and your baby. Don’t wait until you’re in crisis. Talk to your provider early. There’s no shame in needing help.

Comments (10)

  • Sheryl Lynn

    Sheryl Lynn

    3 Dec 2025

    Let’s be real-this isn’t about ‘risks’ anymore, it’s about societal coercion disguised as caution. We’ve pathologized maternal self-preservation into a moral failing. If you’re drowning in serotonin deficiency, denying yourself a lifeline because some 1980s-era fearmongering about ‘fetal toxicity’ still lingers in OB-GYN waiting rooms? That’s not prudence. That’s patriarchy in Prozac form. Sertraline isn’t a poison; it’s a pause button on a spiraling collapse. And if your doctor still whispers ‘paroxetine’ like it’s a forbidden spell, fire them. The data’s been out since 2018. We’re not babysitting embryos-we’re saving mothers.

  • Paul Santos

    Paul Santos

    4 Dec 2025

    Interesting how we frame this as a binary-meds vs. suffering-but what’s rarely acknowledged is the epistemological rupture: we’re treating neurochemical imbalance as if it’s a glitch in the machine, when it’s more like a symphony out of tune. SSRIs don’t ‘fix’ depression-they modulate the frequency. And yes, the placenta’s a filter, not a wall. But here’s the real paradox: the very systems designed to protect the fetus are the same ones that silence the mother’s voice. We measure risk in percentages, but the cost of silence? That’s measured in silent cribs and empty rocking chairs. 🤔

  • Eddy Kimani

    Eddy Kimani

    5 Dec 2025

    Just wanted to add a nuance the article didn’t fully explore: pharmacogenomics. About 40% of folks are CYP2D6 poor metabolizers-that means sertraline sticks around longer in their system. If you’re on 50mg and feeling foggy, you might actually be overmedicated. Genetic testing isn’t sci-fi anymore; it’s covered by most insurances. Ask your prescriber for a PharmGKB report. Also-PPHN risk drops to baseline if you taper off SSRIs by week 36. Timing matters more than we think.

  • Chelsea Moore

    Chelsea Moore

    6 Dec 2025

    STOP. JUST. STOP. This is why we’re raising a generation of emotionally stunted, chemically dependent zombies. You’re telling women to take a drug that alters brain chemistry during the most sacred, vulnerable time of their lives? And you call it ‘safe’? What about the soul? What about natural healing? What about prayer? This isn’t medicine-it’s corporate manipulation disguised as science. I’ve seen women cry in my support group because they feel like monsters for taking pills. And now you’re justifying it with stats? 🙄💔

  • John Biesecker

    John Biesecker

    7 Dec 2025

    Man, this whole thread feels like a TED Talk in a tornado. I get the data, I do. But what about the quiet ones? The ones who don’t have access to psychiatrists, who can’t afford therapy, who just want to hold their baby without crying? SSRIs aren’t magic, but they’re sometimes the only bridge between survival and surrender. I took sertraline during both pregnancies. My kids are 8 and 11 now-wild, creative, hilarious. No autism. No anxiety. Just two kids who know their mama showed up. 🙌💊

  • Allan maniero

    Allan maniero

    8 Dec 2025

    I think we need to sit with the discomfort here. The data is clear, yes-but the emotional weight of choosing a medication during pregnancy isn’t just clinical. It’s existential. Many women feel they’re betraying their bodies, their intuition, their ancestral wisdom. And while I respect the science, I also honor the fear. Maybe the real answer isn’t just which SSRI to take, but how we create space for women to feel heard before they ever reach the prescription pad. A warm hand, a listening ear, a non-judgmental provider-sometimes that’s the first dose that matters.

  • Anthony Breakspear

    Anthony Breakspear

    9 Dec 2025

    Look, I’ve been there. Pregnant, crying in the shower because I couldn’t get out of bed, and my OB said, ‘Just try yoga.’ Yoga? I couldn’t even lift my damn laundry basket. Sertraline saved my life. My daughter is 4 now, runs like a cheetah, loves dinosaurs, and thinks her mom is the funniest person on earth. The ‘risks’? Tiny. The cost of not taking it? Unforgivable. Don’t let fear make you a ghost in your own life. You’re not broken-you’re human. And humans need help sometimes. That’s not weakness. That’s wisdom. 💪❤️

  • Zoe Bray

    Zoe Bray

    11 Dec 2025

    It is imperative to underscore that the clinical recommendations outlined herein are grounded in longitudinal, population-based cohort studies with robust confounder adjustment, including maternal BMI, socioeconomic status, prenatal care utilization, and comorbid anxiety disorders. The relative risk of major congenital malformations remains statistically indistinguishable from background population rates for sertraline, escitalopram, and citalopram. Furthermore, the American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 219 (2020) explicitly endorses SSRI continuation in pregnancy when indicated, citing Level A evidence. Discontinuation should only be considered within a structured, multidisciplinary care plan.

  • Girish Padia

    Girish Padia

    12 Dec 2025

    I am from India. We don't take pills for sadness. We have family. We have god. We have chai. Why do you need chemical help? This is not science. This is weakness. Your children will suffer.

  • Saket Modi

    Saket Modi

    13 Dec 2025

    LMAO at all these ‘data-driven’ takes. You think you’re so smart with your percentages and studies, but what about the woman who took SSRIs and her kid got diagnosed with autism at 3? You just call it ‘correlation’? What about her grief? You’re all just numb to the real cost. 😔

Write a comment